Physician profile
Eric James Ablott
NPI 1356629026
$2,154.69
in general payments reported to CMS, 2019-2025
11 companies · $172 in 2025
The $172 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $170 · 2020: $185 · 2021: $409 · 2022: $641 · 2023: $540 · 2024: $36.68 · 2025: $172.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $749.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $749.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $495.83 | 2021-2025 | Precision7, Total30, Precision 1 |
| Coopervision INC. | $412.75 | 2019-2025 | Myday Contact Lens, Misight Contact Lens |
| Bausch & Lomb Americas INC. | $350.06 | 2022-2023 | Infuse |
| Topcon Healthcare, INC. | $222.31 | 2019-2023 | |
| Maculogix, INC. | $161.44 | 2021 | |
| Allergan, INC. | $144.70 | 2021 | |
| Glaukos Corporation | $139.85 | 2022 | |
| Oyster Point Pharma, INC. | $109.12 | 2022 | |
| Lkc Technologies, INC. | $72.13 | 2023 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $36.59 | 2020-2021 | |
| Optos, INC. | $9.91 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Ablott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.